Multiple cell types and pathways in the myocardium

"Multiple cell types and pathways in the myocardium" describes the complex landscape of the heart’s cellular and molecular environment. The myocardium contains various cell types—including cardiomyocytes, cardiac fibroblasts, endothelial cells, and immune cells—that interact via signaling pathways and paracrine mechanisms to regulate heart function, respond to injury, and promote disease processes like fibrosis, hypertrophy, and inflammation. Therapeutic strategies for cardiac pathologies often focus on modulating these cell types or targeting key pathways (e.g., TGF-β, renin–angiotensin–aldosterone system, metabolic pathways, PI3K/Akt, MAPK, and others) to prevent or reverse maladaptive remodeling, cell death, and heart failure[1][2][3][4][5]. However, "multiple cell types and pathways" is not a single molecular target, nor does it represent a druggable entity, but rather an overarching concept in cardiac pathophysiology research.